Endogenous secretory RAGE in obese women: Association with platelet activation and oxidative stress

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages

  Vazzana, Natale ^a   Guagnano, Maria Teresa ^a   Cuccurullo, Chiara ^b   Ferrante, Elisabetta ^a   Lattanzio, Stefano ^a   Liani, Rossella ^a   Romano, Mario ^a   Davì, Giovanni ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

11 OXOTHROMBOXANE B2; 8 ISOPROSTAGLANDIN F2 ALPHA; ADIPONECTIN; ADVANCED GLYCATION END PRODUCT RECEPTOR; CREATININE;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MULTIPLE LINEAR REGRESSION ANALYSIS; NORMAL HUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; THROMBOCYTE ACTIVATION; URINALYSIS; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DINOPROST; FEMALE; HUMANS; LINEAR MODELS; LIPID PEROXIDATION; LIPIDS; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PLATELET ACTIVATION; RECEPTORS, IMMUNOLOGIC; RISK; THROMBOXANE B2; WEIGHT LOSS;

EID: 84866159881     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1473     Document Type: Article

References (20)

1. Vazzana N, Santilli F, Sestili S, Cuccurullo C, Davi G 2011 Determinants of increased cardiovascular disease in obesity and metabolic syndrome. Curr Med Chem 18:5267-5280
2. Santilli F, Vazzana N, Bucciarelli LG, DavìG2009 Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem 16:940-952
3. Ueno H, Koyama H, Shoji T, Monden M, Fukumoto S, Tanaka S, Otsuka Y, Mima Y, Morioka T, Mori K, Shioi A, Yamamoto H, Inaba M, Nishizawa Y 2010 Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse. Atherosclerosis 211:431-436
4. Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, Goova MT, Moser B, Kislinger T, Lee DC, Kashyap Y, Stern DM, Schmidt AM 2002 RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 106:2827-2835 (Pubitemid 35396983)
5. Devangelio E, Santilli F, Formoso G, Ferroni P, Bucciarelli L, Michetti N, Clissa C, Ciabattoni G, Consoli A, Davì G 2007 Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic Biol Med 43:511-518 (Pubitemid 47058227)
6. Hudson BI, Carter AM, Harja E, Kalea AZ, Arriero M, Yang H, Grant PJ, Schmidt AM 2008 Identification, classification, and expression of RAGE gene splice variants. FASEB J 22:1572-1580 (Pubitemid 351656797)
7. Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, Shoji T, Tamei H, Matsuki H, Sakurai S, Yamamoto Y, Yonekura H, Watanabe T, Yamamoto H, Nishizawa Y 2005 Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 25:2587-2593 (Pubitemid 43732283)
8. Davì G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, Patrono C 2002 Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288:2008-2014 (Pubitemid 35204691)
9. Gawlowski T, Stratmann B, Ruetter R, Buenting CE, Menart B, Weiss J, Vlassara H, Koschinsky T, Tschoepe D 2009 Advanced glycation end products strongly activate platelets. Eur J Nutr 48:475-481
10. Varo N, Libby P, Nuzzo R, Italiano J, Doria A, Schönbeck U 2005 Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products. Diab Vasc Dis Res 2:81-87 (Pubitemid 40827001)
11. American Diabetes Association 2012 Diagnosis and classification of diabetes mellitus. Diabetes Care 35:S64-S71
12. 2000 Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i-xii, 1-253
13. Ciabattoni G, Maclouf J, Catella F, Fitz Gerald GA, Patrono C 1987 Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. Biochim Biophys Acta 918:293-297 (Pubitemid 17065554)
14. Wang Z, Ciabattoni G, Créminon C, Lawson J, Fitzgerald GA, Patrono C, Maclouf J 1995 Immunological characterization of urinary 8-epi-prostaglandin F2 α excretion in man. J Pharmacol Exp Ther 275:94-100
15. Choi KM, Yoo HJ, Kim HY, Lee KW, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH 2009 Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness. Int J Cardiol 132:96-101
16. Colhoun HM, Betteridge DJ, Durrington P, Hitman G, Neil A, Livingstone S, Charlton-Menys V, Bao W, Demicco DA, Preston GM, Deshmukh H, Tan K, Fuller JH 2011 Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial. Diabetes 60:2379-2385
17. Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran Jr LJ, Taguchi A, Olson K, Bucciarelli L, Goova M, Hofmann MA, Cataldegirmen G, D'Agati V, Pischetsrieder M, Stern DM, Schmidt AM 2001 Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 21:905-910 (Pubitemid 34168644)
18. Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, Zhou X, Qu W, Lu Y, Stern DM, Schmidt AM, Lincoff AM, Topol EJ 2003 Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 107:2238-2243 (Pubitemid 36547219)
19. Davì G, Patrono C 2007 Platelet activation and atherothrombosis. N Engl J Med 357:2482-2494
20. Espiritu DJ, Mazzone T 2008 Oxidative stress regulates adipocyte apolipoprotein E and suppresses its expression in obesity. Diabetes 57:2992-2998